Adoption status of SMA techniques
| Country | Developed countries* | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| USA | UK | Australia | New Zealand | Italy | Slovenia | |||||||||||||||
| Study | Guilding et al. (2000) | Cravens and Guilding (2001) | Guilding et al. (2000) | Cadez and Guilding (2007) | Nuhu et al. (2017) | Guilding et al. (2000) | Cinquini and Tenucci (2007) | Cinquini and Tenucci (2010) | Cescon et al. (2019) | Cadez and Guilding (2007) | ||||||||||
| Sample size | 127 | 120 | 63 | 26 | 127 | 124 | 92 | 92 | 55 | 134 | ||||||||||
| Scale used | 1–7 | 1–7 | 1–7 | 1–7 | 1–7 | 1–7 | 1–7** | 1–7** | 1–7 | 1–7 | ||||||||||
| Mean | Rank | Mean | Rank | Mean | Rank | Mean | Rank | Mean | Rank | Mean | Rank | Mean | Rank | Mean | Rank | Mean | Rank | Mean | Rank | |
| ABC/M** | NA | 3.54 | 6 | NA | NA | 4.02 | 3 | NA | 3.51 | 12 | 3.27 | 9 | NA | NA | ||||||
| Attribute costing | 2.37 | 10 | NA | 1.91 | 10 | 1.71 | 15 | NA | 2.54 | 9 | 5.28 | 1 | NA | 4.03 | 11 | 3.60 | 9 | |||
| LCC** | 2.73 | 9 | 2.73 | 10 | 2.60 | 8 | 2.21 | 12 | NA | 2.43 | 10 | 3.19 | 14 | 2.92 | 11 | 4.29 | 10 | 2.90 | 12 | |
| Quality costing | 3.07 | 8 | 3.07 | 9 | 3.11 | 6 | 1.67 | 16 | NA | 3.46 | 5 | 4.31 | 7 | 4.12 | 4 | 4.60 | 8 | 4.31 | 2 | |
| Strategic costing | 3.43 | 5 | NA | 3.72 | 5 | 3.33 | 7 | NA | 3.44 | 6 | 4.42 | 6 | NA | NA | 4.13 | 4 | ||||
| Target costing | 3.19 | 6 | 3.19 | 7 | 2.90 | 7 | 2.00 | 14 | 4.16 | 2 | 3.16 | 7 | 3.84 | 9 | 3.62 | 6 | 4.92 | 5 | 3.64 | 8 |
| VCC** | 3.15 | 7 | 3.15 | 8 | 2.60 | 8 | 2.63 | 9 | 2.40 | 5 | 3.15 | 8 | 3.67 | 11 | 3.43 | 8 | 5.03 | 4 | 3.90 | 7 |
| CCA** | 4.09 | 4 | 4.09 | 4 | 4.37 | 4 | 3.96 | 4 | NA | 3.91 | 4 | 4.14 | 8 | 3.95 | 5 | 4.54 | 9 | 3.38 | 10 | |
| CPM** | 4.93 | 1 | 4.93 | 1 | 5.20 | 1 | 4.40 | 1 | NA | 4.95 | 1 | 4.84 | 4 | 4.69 | 2 | 5.56 | 2 | 4.31 | 2 | |
| CPAFS** | 4.50 | 2 | 4.50 | 3 | 4.78 | 2 | 4.04 | 3 | NA | 4.17 | 3 | 4.61 | 5 | 4.44 | 3 | 4.63 | 7 | 4.47 | 1 | |
| CPA** | NA | NA | NA | 3.50 | 6 | NA | NA | 4.99 | 2 | 4.86 | 1 | NA | 3.90 | 7 | ||||||
| LTCPA** | NA | NA | NA | 2.35 | 11 | NA | NA | NA | NA | NA | 2.70 | 13 | ||||||||
| VCA** | NA | NA | NA | 2.17 | 13 | NA | NA | NA | NA | NA | 2.08 | 14 | ||||||||
| Benchmarking | NA | 4.59 | 2 | NA | 4.36 | 2 | 4.53 | 1 | NA | 3.82 | 10 | 3.61 | 7 | NA | 3.92 | 6 | ||||
| Brand valuation | 2.35* | 11 | NA | 2.50 | 9 | 2.52 | 9 | NA | 2.16 | 11 | NA | NA | 4.74 | 6 | 3.34 | 11 | ||||
| IPM/BSC** | NA | 4.00 | 5 | NA | 2.83 | 8 | 3.16 | 4 | NA | 3.43 | 13 | 3.17 | 10 | 5.34 | 3 | 3.94 | 5 | |||
| Strategic pricing | 4.36 | 3 | NA | 4.73 | 3 | 3.88 | 5 | NA | 4.63 | 2 | 4.91 | 3 | NA | 5.72 | 1 | 4.29 | 3 | |||
| Country | Developed countries* | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| USA | UK | Australia | New Zealand | Italy | Slovenia | |||||||||||||||
| Study | ||||||||||||||||||||
| Sample size | 127 | 120 | 63 | 26 | 127 | 124 | 92 | 92 | 55 | 134 | ||||||||||
| Scale used | 1–7 | 1–7 | 1–7 | 1–7 | 1–7 | 1–7 | 1–7** | 1–7** | 1–7 | 1–7 | ||||||||||
| Mean | Rank | Mean | Rank | Mean | Rank | Mean | Rank | Mean | Rank | Mean | Rank | Mean | Rank | Mean | Rank | Mean | Rank | Mean | Rank | |
| ABC/M** | NA | 3.54 | 6 | NA | NA | 4.02 | 3 | NA | 3.51 | 12 | 3.27 | 9 | NA | NA | ||||||
| Attribute costing | 2.37 | 10 | NA | 1.91 | 10 | 1.71 | 15 | NA | 2.54 | 9 | 5.28 | 1 | NA | 4.03 | 11 | 3.60 | 9 | |||
| LCC** | 2.73 | 9 | 2.73 | 10 | 2.60 | 8 | 2.21 | 12 | NA | 2.43 | 10 | 3.19 | 14 | 2.92 | 11 | 4.29 | 10 | 2.90 | 12 | |
| Quality costing | 3.07 | 8 | 3.07 | 9 | 3.11 | 6 | 1.67 | 16 | NA | 3.46 | 5 | 4.31 | 7 | 4.12 | 4 | 4.60 | 8 | 4.31 | 2 | |
| Strategic costing | 3.43 | 5 | NA | 3.72 | 5 | 3.33 | 7 | NA | 3.44 | 6 | 4.42 | 6 | NA | NA | 4.13 | 4 | ||||
| Target costing | 3.19 | 6 | 3.19 | 7 | 2.90 | 7 | 2.00 | 14 | 4.16 | 2 | 3.16 | 7 | 3.84 | 9 | 3.62 | 6 | 4.92 | 5 | 3.64 | 8 |
| VCC** | 3.15 | 7 | 3.15 | 8 | 2.60 | 8 | 2.63 | 9 | 2.40 | 5 | 3.15 | 8 | 3.67 | 11 | 3.43 | 8 | 5.03 | 4 | 3.90 | 7 |
| CCA** | 4.09 | 4 | 4.09 | 4 | 4.37 | 4 | 3.96 | 4 | NA | 3.91 | 4 | 4.14 | 8 | 3.95 | 5 | 4.54 | 9 | 3.38 | 10 | |
| CPM** | 4.93 | 1 | 4.93 | 1 | 5.20 | 1 | 4.40 | 1 | NA | 4.95 | 1 | 4.84 | 4 | 4.69 | 2 | 5.56 | 2 | 4.31 | 2 | |
| CPAFS** | 4.50 | 2 | 4.50 | 3 | 4.78 | 2 | 4.04 | 3 | NA | 4.17 | 3 | 4.61 | 5 | 4.44 | 3 | 4.63 | 7 | 4.47 | 1 | |
| CPA** | NA | NA | NA | 3.50 | 6 | NA | NA | 4.99 | 2 | 4.86 | 1 | NA | 3.90 | 7 | ||||||
| LTCPA** | NA | NA | NA | 2.35 | 11 | NA | NA | NA | NA | NA | 2.70 | 13 | ||||||||
| VCA** | NA | NA | NA | 2.17 | 13 | NA | NA | NA | NA | NA | 2.08 | 14 | ||||||||
| Benchmarking | NA | 4.59 | 2 | NA | 4.36 | 2 | 4.53 | 1 | NA | 3.82 | 10 | 3.61 | 7 | NA | 3.92 | 6 | ||||
| Brand valuation | 2.35* | 11 | NA | 2.50 | 9 | 2.52 | 9 | NA | 2.16 | 11 | NA | NA | 4.74 | 6 | 3.34 | 11 | ||||
| IPM/BSC** | NA | 4.00 | 5 | NA | 2.83 | 8 | 3.16 | 4 | NA | 3.43 | 13 | 3.17 | 10 | 5.34 | 3 | 3.94 | 5 | |||
| Strategic pricing | 4.36 | 3 | NA | 4.73 | 3 | 3.88 | 5 | NA | 4.63 | 2 | 4.91 | 3 | NA | 5.72 | 1 | 4.29 | 3 | |||
Note(s): *No prior studies available in the context of developing economies. **ABC/M = Activity-based costing/management, LCC = Life cycle costing, VCC = Value chain costing, CCA = Competitor cost assessment, CPM = Competitive position monitoring, CPAFS = Competitor performance appraisal based on financial statements, CPA = Customer profitability analysis, LTCPA = Lifetime customer profitability analysis, VCA= Valuation of customers as assets, IPM = Integrated performance measurement, BSC = Balanced scorecard
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.